Evidence map›Paper›PMID 41057283›Full record

ArticleGenes to cells : devoted to molecular & cellular mechanisms2025

m

Rei Gibu, Kodai Gibu, Kako Suzuki, Yuetsu Tanaka, Kaoru Uchimaru, Makoto Yamagishi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes to cells : devoted to molecular & cellular mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The mJournal of virology · 2026
    Article
  2. mGenes to cells : devoted to molecular & cellular mechanisms · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rei GibuLaboratory of Viral Oncology and Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Kodai GibuGeological Survey of Japan, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan.
Kako SuzukiLaboratory of Viral Oncology and Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Yuetsu TanakaLaboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Okinawa, Japan.
Kaoru UchimaruLaboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
Makoto YamagishiLaboratory of Viral Oncology and Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8142-4686

Funding

Japan Agency for Medical Research and Development JP25ama221534Japan Agency for Medical Research and Development JP25fk0108672Japan Agency for Medical Research and Development JP25wm0325056Japan Science and Technology Agency JPMJSP2108Japan Society for the Promotion of Science JP24K02317
6 · The paper itself

Abstract

Human T-cell Leukemia Virus Type 1 (HTLV-1) is a pathogenic human retrovirus that is responsible for intractable diseases such as adult T-cell leukemia-lymphoma (ATL), a malignancy with a poor patient prognosis. Although recent studies have delineated several genomic, epigenomic, and transcriptomic abnormalities associated with HTLV-1, to date the importance of epitranscriptomic modifications, particularly N

Indexed as

AdenosineGene Products, taxHuman T-lymphotropic virus 1RNA, ViralGene Expression Regulation, ViralHumansLeukemia-Lymphoma, Adult T-CellMethylationRNA, MessengerRNA MethylationAdenosineGene Products, taxN-methyladenosineRNA, MessengerRNA, Viraltax protein, Human T-lymphotrophic virus 1

Identifiers

PMID41057283
PMCPMC12504147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.